SLC7A11 and cardiomyopathy: It was first revealed in vivo that membrane protein SLC7A11 can effectively reverse cardiomyopathy caused by ferritin deficiency by blocking ferroptosis in cardiomyocytes, which is expected to become a new target for the prevention and treatment of heart diseases [9].